chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1515: Client c/o nuasea after vaccine MCV4; stated "I need to throw up"; BP was 70/40. Placed in a supine position with feet elevated; BP 110/80; sitting position BP 100/80.
Hospitalization: 9/7/2022 - 9/11/2022 Presentation to the ED: UNABLE TO RECEIVE OUTPATIENT DIALYSIS D/T BEING COVID +.  COVID-19 + date: 9/7/22. Treatment: PATIENT IS ASYMPTOMATIC AND WAS NOT GIVEN ADDITIONAL MEDICATIONS TO TREAT COVID. Discharge to: HOME.
regurgitated "possibly 1/3 to 1/2" of the oral vaccine following administration; regurgitated "possibly 1/3 to 1/2" of the oral vaccine following administration; This spontaneous report was received from a physician referring to a 6-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.       On an unknown date, the patient was vaccinated with the final dose in the 3-dose series of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (2 ml; strength, lot# and expiration date were not reported) orally (PO) for prophylaxis, and the patient regurgitated possibly 1/3 to 1/2 of the oral vaccine following administration (infantile spitting up and accidental underdose). The patient sought medical attention and no treatment was given for both events. The outcome of infantile spitting up was unknown.     The causality between infantile spitting up and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not provided.
a little rash; on my left arm, small bumps started to populate all over; This spontaneous case was reported by a consumer and describes the occurrence of RASH (a little rash) and VACCINATION SITE MASS (on my left arm, small bumps started to populate all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 051C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (a little rash) and VACCINATION SITE MASS (on my left arm, small bumps started to populate all over). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) on 11-Aug-2021 at an unspecified dose and frequency. At the time of the report, RASH (a little rash) and VACCINATION SITE MASS (on my left arm, small bumps started to populate all over) outcome was unknown.        No concomitant drug information provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.. The company physician considers the reported events as non-serious, because there is no apparent rationale to deal them as serious.   This case was linked to MOD-2021-289677 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Follow up received contain no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.. The company physician considers the reported events as non-serious, because there is no apparent rationale to deal them as serious
Developed urticaria, fever, joint pain & swelling approximately 8 hours after receiving DTaP #5, IPV #4.
April 24 second dose: no side effects April 25 sore/aches, headache, and my voice was horse (in and out most of the day April 26 sore/aches, headache, congestion, voice was back to normal April 27 headache and voice horse again most of the day.
Developed acute pericarditis on 2/14/2021. Completely healthy 42 yr old with no recent illnesses other then the vaccine. Developed myalgia, severe headache, and slightly elevated blood pressures 24 hours post second vaccine. Then 4 weeks later acute pericarditis.
Edema, redness left upper arm.  Oral steroids prescribed 9/10/21, outcome unknown at this time.
2/14/22 @ 11:00 pm-while relaxing watching TV-Sudden onset of racing Heart rate(127) & high blood pressure( 165/95 Light headed, nauseous, jittery 2/15/22-8:30am- BP 141/77 HR 89 2/15/22-4:40pm-BP 121/59 HR 79 2/16/22-8:30am-BP 126/66 HR 65 Called PCP 2/14 -9:30 am- waited til 4:40 pm for return call, they advised me since stats were back to normal there was nothing more to do, said they would follow-up 2/16 am but never heard from them
About 5 minutes after vaccinnation patient felt dizzy, fell to her knees, and was nauseaous. She threw up a few times. She complained of being tired and drank some water and snicker bars which she ate while sitting. She felt better gradually and ws able to leave with her father.
This spontaneous report as received from a clinical medical assistant refers to an unspecified patients of unknown age and gender. There was no medical history, drug reactions/allergies and concomitant medication provided. On 20-MAY-2015, the unspecified patients were vaccinated with an improperly stored doses of RECOMBIVAX HB (dose, route, lot #, therapy type and expiration date were not reported). There was no adverse effect reported. This is one of several reports receivd from the same reporter. Additional information has been requested.
Vaccination was administered on 10/20/2015. The patient noticed itching at the site of injection on 10/26/15 and called the pharmacy. She was told to take BENADRYL and apply BENADRYL cream. No fever. She stated it was going away but not completely. About a week later, site was sore, swelling at top of shoulder and elbow and back of her neck felt bumpy.
severe arm pain, inability to move arm independently, muscle/body ache, fever, thunderbolt headache
Patient is getting the 2 dose in the series of 2. Patient got the dose in the morning and she had to wake up at night as she was feeling hot and when she checked herself she had rash on her chest and the arm on which she got the vaccine. she has mild soreness of the arm when she came back  to the pharmacy at 11.00 am
Booster; Sudden onset Afib with RVR 3 days after the booster; This is a spontaneous report from a contactable physician. This physician reported for a 44-year-old female patient that:  A 44-year-old- non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) (lot number: unknown), dose 3 via an unspecified route of administration on an unspecified date (age at vaccination: 44-years-old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. The patient was not pregnant at the time of vaccination. Relevant medical history included hypertension, obesity. It was unknown that the patient was diagnosed with COVID-19Prior to vaccination. Concomitant medication(s) included losartan (LOSARTAN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE); nifedipine (NIFEDIPINE) taken for an unspecified indication, start and stop date were not reported (received within 2 weeks of vaccination). Historical vaccine included second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 25Feb2021 (at the age of 44-years-old) as a DOSE 2, SINGLE for COVID-19 immunization and first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 18Mar2021 (at the age of 44-years-old) as a DOSE 1, SINGLE for COVID-19 immunization and experienced Allergy. It was unknown that the patient received any other vaccines within 4 weeks prior to the COVID vaccine. On 12Nov2021, patient experienced sudden onset Afib with rvr 3 days after the booster. The patient was hospitalized for the events. Patient tested for COVID-19 after vaccination. The patient was hospitalized for sudden onset afib with rvr 3 days after the booster for 1 days. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 13Nov2021 Nasal Swab. The event resulted to visit Emergency room/department or urgent care. Therapeutic measures were taken as a result of sudden onset afib with rvr 3 days after the booster with cardioversion and anticoagulation. The outcome was recovered on an unspecified date.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: As there is limited information in the case provided, the causal association between the event atrial fibrillation and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
After taking the first Pfizer shot there was nothing remarkable that followed.  Following the 2d dose on 25 Mar, patient was feeling tired, and described mental capacity as being foggy.  Lost apatite and wanted to sleep.  Described vision as blurry and couldn't focus.
Hard time walking; Hands and legs are shaking/ Shaking too bad; Discovered couldn't get up from recliner; Got bad chills; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad), MOVEMENT DISORDER (Discovered couldn't get up from recliner) and CHILLS (Got bad chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 092971A) for COVID-19 vaccination.     Concurrent medical conditions included Dizziness.   On 08-Mar-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (Got bad chills). On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad) and MOVEMENT DISORDER (Discovered couldn't get up from recliner). At the time of the report, GAIT DISTURBANCE (Hard time walking), TREMOR (Hands and legs are shaking/ Shaking too bad), MOVEMENT DISORDER (Discovered couldn't get up from recliner) and CHILLS (Got bad chills) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Headache and chills started over night. Heavy fatigue, weak and achy in the morning. Dizzy spells come and go. Nauseous but no vomiting.
sick for 3 days; weakness; low grade fever; chills but not that bad; terrible muscle pain during the night; he next day felt better and by the third day felt tired but was able to do her activities; This spontaneous case was reported by a non-health professional and describes the occurrence of ILLNESS (sick for 3 days), ASTHENIA (weakness), PYREXIA (low grade fever), CHILLS (chills but not that bad) and MYALGIA (terrible muscle pain during the night) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy (seasonal allergies), Drug allergy (Phenergan) and Drug allergy (Sulfa drug). Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), GABAPENTIN and ALPRAZOLAM (XANAX) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (sick for 3 days), ASTHENIA (weakness), PYREXIA (low grade fever), CHILLS (chills but not that bad), MYALGIA (terrible muscle pain during the night) and FATIGUE (he next day felt better and by the third day felt tired but was able to do her activities). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg four times per day. At the time of the report, ILLNESS (sick for 3 days), ASTHENIA (weakness), PYREXIA (low grade fever), CHILLS (chills but not that bad) and MYALGIA (terrible muscle pain during the night) had resolved and FATIGUE (he next day felt better and by the third day felt tired but was able to do her activities) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) Negative.         Concomitant medications was reported as Metoprolol extender release 25mg daily, Lamictol 12.5mg/day. Treatment medications reported by reporter are Zinc 1 tab for the first two days Amoxicillin 875mg twice a day started yesterday (10Sept)
diagnosed her with shingles; rash on the evening on both of the eye lid; right hand middle finger is feeling like shooting pain almost like nerve pain; knee pain; left hand was having tingling like vibrating pain; numbness that stayed about 3-4 minutes maybe longer; body ache; neck pain; ear pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EYELID RASH (rash on the evening on both of the eye lid) and HERPES ZOSTER (diagnosed her with shingles) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical reported history).    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced MYALGIA (body ache), NECK PAIN (neck pain) and EAR PAIN (ear pain). On 05-Feb-2021, the patient experienced EYELID RASH (rash on the evening on both of the eye lid) (seriousness criterion hospitalization). On 06-Feb-2021, the patient experienced HERPES ZOSTER (diagnosed her with shingles) (seriousness criterion hospitalization). On 21-Feb-2021, the patient experienced PARAESTHESIA (left hand was having tingling like vibrating pain) and HYPOAESTHESIA (numbness that stayed about 3-4 minutes maybe longer). On an unknown date, the patient experienced NEURALGIA (right hand middle finger is feeling like shooting pain almost like nerve pain) and ARTHRALGIA (knee pain). On 21-Feb-2021, PARAESTHESIA (left hand was having tingling like vibrating pain) and HYPOAESTHESIA (numbness that stayed about 3-4 minutes maybe longer) had resolved. At the time of the report, EYELID RASH (rash on the evening on both of the eye lid), HERPES ZOSTER (diagnosed her with shingles), MYALGIA (body ache), NECK PAIN (neck pain), EAR PAIN (ear pain), NEURALGIA (right hand middle finger is feeling like shooting pain almost like nerve pain) and ARTHRALGIA (knee pain) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever started 8/6 after vaccines for 36hrs, rash started 8/7/2019.  8/8/2019 seen here in our office and also sent to dermatology for eval, concerns for allergic reaction. Admitted to Hospital for observation 8/8/2019. Given steroid course and monitored.
Vaccine remained in the freezer past the recommended guidelines (14 days). Once discovered, Pfizer was contacted but did not have stability data to support acceptability of the product greater than 31 days in the freezer. All patients that were administered vaccine past 31 days were contacted and given an option to be re-vaccinated based on their doctor'S recommendation or Health Agency guidance.
ERROR: Age- UNAUTHORIZED AGE GROUP (17 years old, Moderna EUA approved only for adults 18 years and older. Patient signed consent form with incorrect DOB indicating age greater than 18yo). Event discovered and forwarded to for VAERS reporting. Signs and symptoms: None known Diagnosis and treatment: None known Outcome: No adverse reaction reported
fever lasting over 12 hours, fever up to topped at 102, extreme fatigue, extreme headache, stuffy nose Symptoms lasted 36 hours.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received bnt162b2 (BNT162B2 NOS), in Jun2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 74 years, in right arm for covid-19 immunisation. Vaccine administration time reported as 02:00 PM. The patient's relevant medical history included: "known allergies: sulfa drugs" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received PAXLOVID (lot number reported as 00069-1085-30) as treatment of COVID-19 from 17Sep2023 to 21Sep2023.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Headache; Two days of deep fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Two days of deep fatigue) and HEADACHE (Headache) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and ATORVASTATIN for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Two days of deep fatigue) and HEADACHE (Headache). At the time of the report, FATIGUE (Two days of deep fatigue) and HEADACHE (Headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment for the events included none.
Lower lip swollen with a multitude of sores on lip and on inside of lip.  Only a few sores on the inside of the top lip.  A few sores inside the mouth on both sides by the back teeth.  Teeth and gums extremely sore so much so that I did not eat anything that needed to be chewed for several days.Fflossing teeth was extremely painful.  Doctor prescribed Cephalexin 500 mg three times a day Quantity 30 and  Acyclovir Ointnent 5% every 3 hours for 7 days.    After 7 days teeth and gums almost 100% good.  Only some minor soreness on the front lower teeth.  Sores on lips 99% better only one minor sore left.  Sores on the inside of mouth gone.
PATIENT CALLED ON 03/01/2022 REPORTING A RED SPOT ALMOST TOWARDS HER ELBOW WHICH IS HARD AND ITCHING. SHE ALSO HAD HEADACHE WHICH IS ALMOST GONE NOW.
Patient developed hives on her arms, chest, back, shoulders on 11/16/2004. Seen at Student Health Center 11/17/04. Treated with Claritan, Benadryl QHS, Cortisone cream. Reports improvement of hives on 11/18/04 (phone call).
pt recvd vax; fever low grade p/ vax; brief sz; adm to hosp;was found to have UTI at this time;
Pt was given 2nd dose vaccine under the age of 12 mother lied on application stating the pts birthdate was incorrect on application when actual birthdate is not as stated on application.
could not get out of bed; She could not walk for 2 days/ She is finally getting mobility with one leg; had severe knee and joint pain; she was tired; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MOBILITY DECREASED (could not get out of bed), GAIT INABILITY (She could not walk for 2 days/ She is finally getting mobility with one leg), ARTHRALGIA (had severe knee and joint pain) and FATIGUE (she was tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Her mother previously received 3 doses of the Pfizer vaccine Dose 1), Pfizer vaccine (Dose 3) and Pfizer vaccine (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine.    On 02-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2022, the patient experienced MOBILITY DECREASED (could not get out of bed), GAIT INABILITY (She could not walk for 2 days/ She is finally getting mobility with one leg), ARTHRALGIA (had severe knee and joint pain) and FATIGUE (she was tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (could not get out of bed), ARTHRALGIA (had severe knee and joint pain) and FATIGUE (she was tired) outcome was unknown and GAIT INABILITY (She could not walk for 2 days/ She is finally getting mobility with one leg) was resolving.            Patient was not on any concomitant medications. It was reported that, patient was super active before vaccination. Patient was hoping that she would be able to have mobility in the other leg. All the symptoms started 24 hours after vaccination.
Upon second dose I have constant twitching at and around injection site of left upper arm, it is very disturbing and persists to this moment.  I noticed it about 24 hours after the shot.   I also have the totally normal soreness at the injection site that persists to this moment. I did have flu like symptoms (body aches, limb weakness arms and legs, malaise) on  4/28/21 from 1pm till 9pm but has resolved.  The First shot I do not remember which arm, I think it was the left but cannot be certain, but I had no side effects at that time.  I also have a very occasional twitch in my right upper arm that persists to this moment which is similar to the twitch in my left arm but is much much less severe and very infrequent.   Note I have specifically nickel allergy and a number of other minor allergies.   I also used to have benign fastulations that were random though my body which resolved  and has not been an issued since 2017.